Surgical Treatments of Tricuspid Valve Regurgitation After Cardiac Surgery

Guangdong Provincial People's Hospital (Guangdong Provincial Academy of Medical Sciences)

Status: Enrolling

Conditions: Tricuspid Valve Regurgitation; Complications, Longterm Outcome

Treatments: Procedure: Huanlei Huang

Study type: Observational

Funder types: Other

Identifiers

NCT06554119

Guangdong Provincial PHosp

Details and patient eligibility

About

This study aims to present our center's experience in managing postoperative tricuspid valve regurgitation over the past 25years and to analyze the outcomes of these surgical treatments.

Enrollment: 375 estimated patients

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:patients who underwent surgical treatment from 1999 to 2023 for tricuspid valve disease following cardiac surgery

Exclusion Criteria: age <16，severe tricuspid regurgitation secondary to primary pulmonary hypertension, and those with substantial missing case data.

Trial design

375 participants in 2 patient groups

TVR

Description:

tricuspid valve replacement group，

Treatment:

Procedure: Huanlei Huang

TVP

Description:

tricuspid valvuloplasty group

Treatment:

Procedure: Huanlei Huang